James McCarty

1.9k total citations
63 papers, 1.4k citations indexed

About

James McCarty is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, James McCarty has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 25 papers in Infectious Diseases and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in James McCarty's work include Fungal Infections and Studies (15 papers), Pneumonia and Respiratory Infections (13 papers) and Antifungal resistance and susceptibility (11 papers). James McCarty is often cited by papers focused on Fungal Infections and Studies (15 papers), Pneumonia and Respiratory Infections (13 papers) and Antifungal resistance and susceptibility (11 papers). James McCarty collaborates with scholars based in United States, Canada and Mexico. James McCarty's co-authors include David H. Martin, Raymond B. Johnson, S. Hopkins, Robert B. Jones, Tomasz Mroczkowski, James Hedrick, Michael Shan, Robert Tosiello, Constance Keyserling and Kenneth J. Tack and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Infectious Diseases.

In The Last Decade

James McCarty

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James McCarty United States 21 782 399 363 280 212 63 1.4k
Mary Cafferkey Ireland 25 824 1.1× 561 1.4× 280 0.8× 441 1.6× 110 0.5× 69 1.7k
Patricia M. Roblin United States 24 713 0.9× 166 0.4× 733 2.0× 157 0.6× 71 0.3× 64 1.4k
Stuart Levin United States 24 719 0.9× 390 1.0× 260 0.7× 203 0.7× 135 0.6× 78 1.6k
Jay M. Lieberman United States 20 676 0.9× 516 1.3× 279 0.8× 181 0.6× 199 0.9× 31 1.2k
Géraldine Hall United States 19 566 0.7× 622 1.6× 374 1.0× 183 0.7× 47 0.2× 33 1.5k
Patricia Pavèse France 24 644 0.8× 468 1.2× 97 0.3× 209 0.7× 90 0.4× 113 1.6k
M. Rozenberg-Arska Netherlands 27 927 1.2× 425 1.1× 138 0.4× 149 0.5× 259 1.2× 82 1.9k
Carl Kamme Sweden 22 552 0.7× 265 0.7× 250 0.7× 202 0.7× 302 1.4× 54 1.3k
H. Dele Davies Canada 26 1.3k 1.6× 348 0.9× 295 0.8× 1.4k 5.0× 199 0.9× 52 2.4k
Dimitris A. Kafetzis Greece 19 531 0.7× 199 0.5× 131 0.4× 348 1.2× 157 0.7× 36 1.1k

Countries citing papers authored by James McCarty

Since Specialization
Citations

This map shows the geographic impact of James McCarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McCarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McCarty more than expected).

Fields of papers citing papers by James McCarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James McCarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McCarty. The network helps show where James McCarty may publish in the future.

Co-authorship network of co-authors of James McCarty

This figure shows the co-authorship network connecting the top 25 collaborators of James McCarty. A scholar is included among the top collaborators of James McCarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James McCarty. James McCarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
McCarty, James, Lisa Bedell, Jason Mendy, et al.. (2023). Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals. Vaccine. 41(42). 6146–6149. 4 indexed citations
3.
McCarty, James, et al.. (2020). Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2–5 Years in the United States. American Journal of Tropical Medicine and Hygiene. 104(3). 861–865. 6 indexed citations
4.
5.
McCarty, James, et al.. (2015). Cystic Fibrosis: A Novel Pharmacologic Approach to Cystic Fibrosis Transmembrane Regulator Modulation Therapy. Journal of Osteopathic Medicine. 115(9). 546–555. 3 indexed citations
6.
McCarty, James, et al.. (2013). Smart Toe® Implant Versus Buried Kirschner Wire for Proximal Interphalangeal Joint Arthrodesis: A Comparative Study. The Journal of Foot & Ankle Surgery. 52(5). 580–583. 33 indexed citations
7.
McCarty, James, et al.. (2013). Pediatric Coccidioidomycosis in Central California: A Retrospective Case Series. Clinical Infectious Diseases. 56(11). 1579–1585. 25 indexed citations
8.
Schuster, Michael W., E. Anaissie, David D. Hurd, et al.. (2007). Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. 5. 58–59. 2 indexed citations
9.
Jennings, Maureen, et al.. (2003). Comparison of azithromycin and cefadroxil for the treatment of uncomplicated skin and skin structure infections.. PubMed. 72(3). 240–4. 7 indexed citations
10.
McCarty, James, James Hedrick, & W M Gooch. (2000). Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis. Advances in Therapy. 17(1). 14–26. 25 indexed citations
11.
McCarty, James, G. Richard, W Huck, et al.. (1999). A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. The American Journal of Medicine. 106(3). 292–299. 126 indexed citations
12.
Chodosh, Sanford, James McCarty, Stephen A. Farkas, et al.. (1998). Randomized, Double‐Blind Study of Ciprofloxacin and Cefuroxime Axetil for Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis. Clinical Infectious Diseases. 27(4). 722–729. 50 indexed citations
13.
Pons, Vincent, Deborah Greenspan, Francina Lozada‐Nur, et al.. (1997). Oropharyngeal Candidiasis in Patients with AIDS: Randomized Comparison of Fluconazole Versus Nystatin Oral Suspensions. Clinical Infectious Diseases. 24(6). 1204–1207. 68 indexed citations
14.
McLinn, Samuel E., et al.. (1995). Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulate in the empiric treatment of acute otitis media. The Pediatric Infectious Disease Journal. 14(Supplement). S108–114. 20 indexed citations
15.
Swinehart, James M., Malcolm Sperling, Stephanie Phillips, et al.. (1994). Intralesional accusiteTM-(fluorouracil/epinephrine) injectable gel for treatment of condylomata acuminata: A phase III clinical study. Journal of Investigative Dermatology. 103(3). 402. 2 indexed citations
16.
McCarty, James, Gary Ruoff, & Kevan Jacobson. (1992). Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population. The American Journal of Medicine. 92(6). S80–S85. 13 indexed citations
17.
Martin, David H., Tomasz Mroczkowski, James McCarty, et al.. (1992). A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis. New England Journal of Medicine. 327(13). 921–925. 203 indexed citations
18.
McCarty, James, et al.. (1988). Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis. Pediatric Pulmonology. 4(4). 201–204. 26 indexed citations
19.
McCarty, James, et al.. (1987). Group B streptococcal soft tissue infections beyond the neonatal period.. PubMed. 147(5). 558–60. 5 indexed citations
20.
McCarty, James, et al.. (1986). Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. The Journal of Pediatrics. 108(5). 721–724. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Cafferkey Breakdown of academic impact, for papers by Patricia M. Roblin Breakdown of academic impact, for papers by Stuart Levin Breakdown of academic impact, for papers by Jay M. Lieberman Breakdown of academic impact, for papers by Géraldine Hall Breakdown of academic impact, for papers by Patricia Pavèse Breakdown of academic impact, for papers by M. Rozenberg-Arska Breakdown of academic impact, for papers by Carl Kamme Breakdown of academic impact, for papers by H. Dele Davies Breakdown of academic impact, for papers by Dimitris A. Kafetzis
Rankless by CCL
2026